皮下注射避孕药的兴起。
The Coming-of-Age of Subcutaneous Injectable Contraception.
机构信息
United States Agency for International Development, Global Health Support Initiative-III, Washington, DC, USA.
United States Agency for International Development, Global Health Fellows Program II, Washington, DC, USA.
出版信息
Glob Health Sci Pract. 2018 Mar 30;6(1):1-5. doi: 10.9745/GHSP-D-18-00050. Print 2018 Mar 21.
Abstract
DMPA-SC is a contraceptive injectable formulation that provides women and couples another important voluntary family planning option. It offers characteristics that many women like, including cost and time savings, and has the potential to be delivered by a range of health care cadres in a variety of service delivery channels.
摘要
DMPA-SC 是一种避孕注射剂，为女性和夫妇提供了另一种重要的自愿计划生育选择。它具有许多女性喜欢的特点，包括节省成本和时间，并且有可能由各种卫生保健人员在各种服务提供渠道中提供。
相似文献
1
The Coming-of-Age of Subcutaneous Injectable Contraception.皮下注射避孕药的兴起。
Glob Health Sci Pract. 2018 Mar 30;6(1):1-5. doi: 10.9745/GHSP-D-18-00050. Print 2018 Mar 21.
2
Statement on injectable contraception. Revised.关于注射用避孕药的声明。修订版。
IPPF Med Bull. 1992 Dec;26(6):4-6.
3
FDA okays limited use of injectable contraceptive.美国食品药品监督管理局批准有限使用注射用避孕药。
JAMA. 1973 Nov 12;226(7):735.
4
New aspects of injectable contraception.可注射避孕的新进展。
Int J Fertil Womens Med. 2001 Jan-Feb;46(1):31-6.
5
Progestin-only contraception: injectables and implants.仅含孕激素的避孕方法：注射剂和植入剂。
Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):795-806. doi: 10.1016/j.bpobgyn.2014.05.003. Epub 2014 Jun 5.
6
DMPA for contraception discussed by international forum of experts.国际专家论坛讨论了用于避孕的醋酸甲羟孕酮。
Netw Int Fertil Res Program. 1979 Oct:2-3.
7
A new approach to fertility control: long-acting injectable progesterones.一种生育控制的新方法：长效注射用孕激素
Adv Fertil Control. 1968;3(3):41-3.
8
Long-acting steroids provide new options.长效类固醇提供了新的选择。
Netw Res Triangle Park N C. 1988 Spring;9(3):1-3, 7.
9
Injectable medroxyprogesterone.注射用甲羟孕酮。
Drug Ther (NY). 1975 Jul;5:139.
10
Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo.于乌约大学教学医院（位于乌约）使用的醋酸甲羟孕酮长效注射避孕法。
Ann Afr Med. 2010 Apr-Jun;9(2):81-5. doi: 10.4103/1596-3519.64751.
引用本文的文献
1
Self-aggregating long-acting injectable microcrystals.自聚集长效注射微晶
Nat Chem Eng. 2025;2(3):209-219. doi: 10.1038/s44286-025-00194-x. Epub 2025 Mar 24.
2
DMPA-SC stock: Cross-site trends by facility type.皮下注射醋酸甲羟孕酮库存：按机构类型划分的跨站点趋势。
Contracept X. 2022 Apr 8;4:100075. doi: 10.1016/j.conx.2022.100075. eCollection 2022.
3
Commodity security frameworks for health planning.卫生规划的商品安全框架。
Explor Res Clin Soc Pharm. 2021 May 17;2:100025. doi: 10.1016/j.rcsop.2021.100025. eCollection 2021 Jun.
4
Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot-Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era.尼日利亚醋酸甲羟孕酮长效注射剂的弹性加速推广（RASuDiN）：COVID-19 时代的中期研究
Open Access J Contracept. 2021 Dec 2;12:187-199. doi: 10.2147/OAJC.S326106. eCollection 2021.
5
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries.疫苗产品创新策略：为产品开发创造有利环境，以在低收入和中等收入国家得到采用。
Vaccine. 2021 Dec 3;39(49):7208-7219. doi: 10.1016/j.vaccine.2021.07.091. Epub 2021 Oct 7.
6
Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda.布基纳法索、刚果民主共和国和乌干达使用皮下注射醋酸甲羟孕酮（DMPA-SC）的相关特征。
Contracept X. 2021 Jan 20;3:100055. doi: 10.1016/j.conx.2021.100055. eCollection 2021.
7
Injectable Depot Medroxy Progesterone Acetate: A Safe Contraceptive Choice in Public Health System of India.注射用醋酸甲羟孕酮：印度公共卫生系统中的一种安全避孕选择。
Int J Prev Med. 2020 Nov 26;11:180. doi: 10.4103/ijpvm.IJPVM_163_19. eCollection 2020.
8
Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda.布基纳法索、刚果民主共和国和乌干达醋酸甲羟孕酮皮下注射剂（DMPA-SC）的使用趋势。
Contracept X. 2019 Nov 9;1:100013. doi: 10.1016/j.conx.2019.100013. eCollection 2019.
本文引用的文献
1
Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries.扩大可注射避孕方法的获得途径：在 4 个非洲国家引入皮下注射醋酸甲羟孕酮（DMPA-SC）的试点结果。
Glob Health Sci Pract. 2018 Mar 30;6(1):55-72. doi: 10.9745/GHSP-D-17-00250. Print 2018 Mar 21.
2
Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.自我注射与医护人员注射皮下储库型醋酸甲羟孕酮对马拉维续用率的影响：一项随机对照试验。
Lancet Glob Health. 2018 May;6(5):e568-e578. doi: 10.1016/S2214-109X(18)30061-5. Epub 2018 Mar 8.
3
Rapid Uptake of the Subcutaneous Injectable in Burkina Faso: Evidence From PMA2020 Cross-Sectional Surveys.布基纳法索皮下注射剂的快速普及：来自 PMA2020 横断面调查的证据。
Glob Health Sci Pract. 2018 Mar 30;6(1):73-81. doi: 10.9745/GHSP-D-17-00260. Print 2018 Mar 21.
4
Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study).一项多中心、开放标签、随机临床试验的原理与设计，该试验比较使用三种常用避孕方法的女性的艾滋病毒发病率和避孕益处（回声研究）
Gates Open Res. 2018 Mar 13;1:17. doi: 10.12688/gatesopenres.12775.2. eCollection 2017.
5
Contribution of Contraceptive Discontinuation to Unintended Births in 36 Developing Countries.避孕措施中断对 36 个发展中国家非意愿妊娠的影响。
Stud Fam Plann. 2017 Sep;48(3):269-278. doi: 10.1111/sifp.12023. Epub 2017 Apr 11.
6
An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.关于激素避孕方法与女性感染艾滋病毒情况的流行病学证据的最新系统评价。
AIDS. 2016 Nov 13;30(17):2665-2683. doi: 10.1097/QAD.0000000000001228.
7
Use of modern contraception increases when more methods become available: analysis of evidence from 1982-2009.更多避孕方法的可及性提高了现代避孕措施的使用率：来自 1982-2009 年的证据分析。
Glob Health Sci Pract. 2013 Jul 26;1(2):203-12. doi: 10.9745/GHSP-D-13-00010. eCollection 2013 Aug.
8
Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal.乌干达和塞内加尔肌肉注射醋酸甲羟孕酮使用者对Sayana® Press可接受性的观察性研究。
Contraception. 2014 May;89(5):361-7. doi: 10.1016/j.contraception.2014.01.022. Epub 2014 Feb 6.
9
Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.乌干达拉凯地区HIV阳性女性对Sayana® Press与肌肉注射醋酸甲羟孕酮的偏好：一项随机交叉试验
Contraception. 2014 May;89(5):385-95. doi: 10.1016/j.contraception.2013.11.008. Epub 2013 Nov 15.
10
Reducing unmet need by supporting women with met need.通过满足有需求的女性来减少未满足的需求。
Int Perspect Sex Reprod Health. 2013 Sep;39(3):133-41. doi: 10.1363/3913313.
Zotero 插件